Abstract
Process flow diagrams like caremaps are common in clinical practice guidelines and treatment texts. However, their context is often limited to a single diagnostic or treatment event. While a method has been proposed for creating a health and disease lifecycle called the health condition timeline (HCT), that method is yet to be demonstrated for an entire health condition. This paper investigates development of an HCT for gestational diabetes mellitus (GDM), and whether the HCT and caremaps it incorporates can be used to support patient care to develop decision support tools. We show that this approach can be used to expedite development of clinical decision-support and clinician- and patient-facing applications. Caremaps, HCT and the decision support tools created with them could improve patient awareness for their condition and reduce the impact of their disease on themselves and the limited resources of our healthcare systems.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
EPSRC grant EP/EP/P009964/1: PAMBAYESIAN: Patient Managed decision-support using Bayes Networks
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The regular Clinical Audit of the Diabetes in Pregnancy (gestational diabetes) pathway that was used to produce anonymised aggregate statistics to train and validate the Bayesian model was approved by the Barts Health NHS Trust. 14/12/2018. Audit ID: 9861 and 08/05/2017. Audit ID: 8268. Requirements for further ERB/IRB or patient consent were waived.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Glossary of Terms
- BN
- Bayesian network
- CBG
- Capillary Blood Glucose
- CPG
- Clinical Practice Guideline
- CPT
- Conditional Probability Table
- DSMW
- Diabetic Specialist Midwife
- EHR
- Electronic Health Record
- EPSRC
- Engineering and Physical Sciences Research Council
- GDM
- Gestational Diabetes Mellitus
- HCT
- Health Condition Timeline
- NICE
- National Institute for Health and Care Excellence
- OGTT
- Oral Glucose Tolerance Test
- PBG
- Plasma Blood Glucose
- RS-EHR
- Realistic Synthetic Electronic Health Records
- RS-HCT
- Realistic Synthetic Health Condition Timeline
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.